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R
ecent advances in lasers and fl  uo-
rescent dyes have made it possi-
ble to observe individual proteins 
as they fold into their mature conforma-
tion or bind to other proteins. Liz Rhoades 
is harnessing these techniques to answer 
questions about the biology of amyloid 
family proteins—whose aggregation is 
associated with neurodegenerative syn-
dromes such as Parkinson’s and Alzheim-
er’s disease (1).
With an undergraduate degree in phys-
ics, followed by graduate and postdoctoral 
work in biophysics (2, 3), Rhoades ap-
proaches her work with a different per-
spective than would a cell biologist, but 
her efforts are helping unravel some en-
during mysteries surrounding amyloid 
proteins, including what structural confor-
mations these proteins normally assume (4). 
They’re also providing insights into what 
induces these proteins to form the aggre-
gates that are the hallmarks of neurodegen-
erative diseases (5). We called Dr. Rhoades 
in her lab at Yale University to fi  nd out 
more about her work and the technologies 
that drive it.
MAJOR CHANGE
What was your ﬁ  rst exposure to science?
It was really when I went to public 
school, where I always had really good 
math and science teachers. 
But I didn’t think about be-
ing a scientist until I was 
already at college; I was 
pretty sure I would be an 
English major when I went 
to University. Then, when I 
got to Duke, I had to take 
the distribution require-
ments—classes that weren’t 
in my main area of study. I 
had started thinking about 
going into environmental 
engineering, so I decided to take some 
basic science classes. At the beginning of 
my sophomore year I needed to take or-
ganic chemistry, but I didn’t register for 
the class in time to get a lab section that 
I liked, so I decided I would take physics 
instead, to get it out of the way. As it 
turned out, I really liked my physics 
class. That was largely due to the profes-
sor, Alec Schramm, who was fantastic, 
even though he wasn’t on the faculty—I 
think he was either a postdoc or a gradu-
ate student at the time. I decided to be-
come a physics major.
What did you plan to do after your 
degree?
Graduate school seemed like a nice op-
tion, as I think it does to many people 
fi  nishing up an undergraduate degree in 
an area where it’s not immediately obvi-
ous what kind of job you’ll do. I’d been 
doing research every summer, but in the 
summer before my senior year, I ended 
up in a biophysics lab at the University 
of Tennessee. I really liked what I was 
doing there, so in my senior year I took a 
lot of biology courses, and I decided I 
really wanted to be in a biophysics grad-
uate program.
You were in graduate school when you 
ﬁ  rst encountered proteins involved in 
amyloid disease…
I did my graduate studies with Ari Gafni 
at the University of Michigan. I was 
studying a peptide called 
Islet Amyloid Polypeptide, 
which is implicated in the 
pathology of type II diabe-
tes. It’s found aggregated 
and deposited in extracel-
lular plaques, and we were 
trying to understand why it 
aggregates and what path-
way leads to the formation 
of aggregates. Although I 
didn’t work on amyloid 
proteins during my first 
postdoc, I ended up coming back to the 
subject for my second postdoc, and that’s 
primarily what we’re working on in my 
group now.
NOTHING TO FRET ABOUT
In your ﬁ  rst postdoc you used Förster 
resonance electron transfer (FRET) to 
look at protein folding…
Yes. In FRET, the excitation state of an 
acceptor fl  uorophore depends on its prox-
imity to a donor fl  uorophore. This means 
that it can be used to detect interactions 
between two proteins, and also as a direct 
conformational probe of a protein. For 
conformational studies, both the donor 
and the acceptor fl  uorophore are attached 
to the same protein, and the relative 
amount of fl  uorescence emission from the 
donor and the acceptor is dependent on 
the conformation of the protein. You can 
get both static information about the states 
that are populated, and information about 
the dynamic interchange between those 
states—in other words, both kinetic and 
equilibrium data. Because we were doing 
FRET measurements on molecules that 
were inside immobilized lipid vesicles, 
we could also follow a single protein for 
an extended period of time and watch it 
































Rhoades studies protein folding and binding using single-molecule 
fluorescence techniques.
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“FCS is a 
powerful 
approach 
to look at 
fluctuations 
that happen 
on [very fast] 
time scales.”
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Why did you do two postdocs?
I had done my fi  rst postdoc in Israel at the 
Weizmann Institute with Gilad Haran. I 
chose to go there because I wanted to work 
abroad. The Institute was a fantastic place to 
work. I really enjoyed my time there. It’s a 
really interesting environment full of very 
talented people from all over the world.
After a couple of years, I was ready to 
wrap up my time in Israel, but I wasn’t cer-
tain I was ready to take up a professorship 
right away. I applied for some faculty posi-
tions anyway, and I was actually offered a 
job at Stockholm University, but I decided 
instead to take another postdoc in Watt 
Webb’s lab at Cornell. I was very excited to 
get the opportunity to work with him.
Why was that?
I’d read so much of his work, and he had 
tools that I really wanted to learn, particu-
larly fl  uorescence correlation spectrosco-
py (FCS). I proposed to him that we study 
an amyloid system using the tools that he 
already had in his lab. The project that I 
initially envisioned—which 
involved using FCS to un-
derstand how an amyloid 
protein called -synuclein 
localizes to specifi  c types of 
model membranes—never 
actually got done. Instead, 
we used FCS to make quan-
titative measurements of 
-synuclein binding to dif-
ferent types of model mem-
branes, which allowed us to 
investigate the role of spe-
cifi  c lipids and of electro-
statics on binding.
CONCENTRATE ON DETAIL
How does FCS work?
Molecules undergo Brownian motion in 
solution. If you use a focused laser as your 
illumination source, the focal volume de-
fi  nes your observation volume. As fl  uores-
cent molecules diffuse by Brownian motion, 
they move in and out of the focal volume, 
which results in fl  uctuations in the fl  uores-
cence intensity measured from this volume. 
From these intensity fl  uctuations, you can 
calculate something called a temporal auto-
correlation curve. Fitting data to this curve 
yields information about the diffusion of the 
molecule and its concentration in solution. 
For example, a compact, folded protein dif-
fuses more quickly than when it’s unfolded, 
aggregated, or bound to another protein.
FCS is also a powerful approach to look 
at fl  uctuations that happen on time scales 
much faster than diffusion. When com-
bined with single-molecule FRET, which 
is useful for longer time scale dynamics, 
you can get very detailed information 
about the conformational 
fl  uctuations of your protein. 
For example, if you’re using 
FRET to monitor the state of 
a folded protein, then as long 
as the protein stays folded, 
it’s going to have constant 
donor and acceptor fl  uoro-
phore intensities—at least 
on a time scale of tens of 
milliseconds, which is what 
you normally use for these 
types of measurements. But 
combining this with the in-
formation from FCS allows 
you to observe the dynamic 
behavior—for example, fluctuations in 
packing state or slight conformational 
changes of the protein in the folded state.
Can this technology be used in intact 
cells, as well?
That’s an advantage of this technique and 
something that has been demonstrated 
elegantly both in cells and, very recently, 
in intact living embryos. The ability to do 
FCS and FRET in a cell or living organ-
ism means that you have the potential to 
look at interactions with native binding 
partners and make quantitative measure-
ments of these interactions in physiolog-
ical systems. One of the projects in my 
lab is to make a structural map of what 
-synuclein looks like in various parts of 
the cell—for example, does it have the 
same structure when it’s associated with 
different cellular substructures?
What else are you working on now that 
you have your own lab at Yale?
-Synuclein is strongly implicated in the 
pathology of Parkinson’s disease, and while 
there are a number of genetic and environ-
mental factors that lead to the disease, the 
primary risk factor is aging. A question we 
are very interested in answering is, how do 
the physiological failures of the aging brain 
lead to the aggregation of what is normally 
a very soluble protein? One aspect of this 
that we’ve been thinking a lot about is the 
role of oxidative stress. Oxidative stress can 
lead to modifi  cations of either lipids or 
proteins. Native interactions, and thus the 
native function, of -synuclein could be 
perturbed by modifi  cations that arise from 
an oxidative environment. We would like 
to understand whether direct oxidative 
modifi  cations to -synuclein either affect 
its ability to function normally or its dys-
functional role in Parkinson’s disease.
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Strong, tightly focused laser light illuminates single-molecule ﬂ  uorescence.
“How do the 
physiological 
failures of the 
aging brain 
lead to the 
aggregation 
of what is 
normally a 
very soluble 
protein?”